hypertension

(redirected from Arterial hypertension)
Also found in: Thesaurus, Medical, Acronyms, Encyclopedia.
Related to Arterial hypertension: Pulmonary Arterial Hypertension

hy·per·ten·sion

 (hī′pər-tĕn′shən)
n.
1.
a. Abnormally elevated arterial blood pressure.
b. Arterial disease marked by chronic high blood pressure.
2. Elevated pressure or tension of a body fluid, as of the intraocular or cerebrospinal fluids.

hypertension

(ˌhaɪpəˈtɛnʃən)
n
(Pathology) pathol abnormally high blood pressure
hypertensive adj, n

hy•per•ten•sion

(ˌhaɪ pərˈtɛn ʃən)

n.
1.
a. elevation of the blood pressure, esp. the diastolic pressure.
b. an arterial disease characterized by this condition.
2. excessive nervous tension.
[1890–95]

hy·per·ten·sion

(hī′pər-tĕn′shən)

hypertension

High blood pressure, often caused by stress, arteriosclerosis, or heart disease.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.hypertension - a common disorder in which blood pressure remains abnormally high (a reading of 140/90 mm Hg or greater)hypertension - a common disorder in which blood pressure remains abnormally high (a reading of 140/90 mm Hg or greater)
cardiovascular disease - a disease of the heart or blood vessels
essential hypertension, hyperpiesia, hyperpiesis - persistent and pathological high blood pressure for which no specific cause can be found
malignant hypertension - severe hypertension that runs a rapid course and damages the inner linings of the blood vessels and the heart and spleen and kidneys and brain; "malignant hypertension is the most lethal form of hypertension"
secondary hypertension - hypertension that is secondary to another disease
white-coat hypertension - temporary rise in blood pressure in the doctor's office
hypotension - abnormally low blood pressure
Translations
hypertenze

hypertension

[ˈhaɪpəˈtenʃən] N (Med) → hipertensión f

hypertension

[ˌhaɪpərˈtɛnʃən] nhypertension f

hypertension

[ˌhaɪpəˈtɛnʃn] n (Med) → ipertensione f

hy·per·ten·sion

n. hipertensión, presión arterial alta;
benign ______ benigna;
essential ______ esencial;
malignant ______ maligna;
portal ______ portal;
primary ______ primaria;
renal ______ renal.

hypertension

n hipertensión f, presión alta (de la sangre) (fam); benign intracranial — hipertensión intracraneal benigna; essential — hipertensión esencial; malignant — hipertensión maligna; portal — hipertensión portal; pulmonary — hipertensión pulmonar; renovascular — hipertensión renovascular; white-coat — hipertensión de bata blanca
References in periodicals archive ?
Humbert M, Morrell N, Archer S, et al: Cellular and molecular pathobiology of pulmonary arterial hypertension.
Although idiopathic pulmonary arterial hypertension, formerly called "primary," is rare, other forms of PAH and associated cor pulmonale are more prevalent than conventionally believed.
In May 2002, United Therapeutics agreed with the FDA to conduct the Phase IV study at the time that Remodulin was approved for the treatment of pulmonary arterial hypertension in patients with NYHA Class II-IV symptoms to diminish symptoms associated with exercise.
TracleerTM, the first orally available dual endothelin receptor antagonist, is already approved and available in major markets worldwide for the treatment of pulmonary arterial hypertension (PAH), a chronic life-threatening condition that severely compromises the function of the lungs and heart.
It has already launched its first product Tracleer[TM], a revolutionary drug for the treatment of pulmondary arterial hypertension.
Global Markets Direct's, 'Pulmonary Arterial Hypertension - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline.
Ralinepag is an oral, selective IP receptor agonist targeting the prostacyclin pathway for the treatment of pulmonary arterial hypertension.
Compared to surgical operation, interventional closure has been recognized in clinic for it can probe the properties of pulmonary arterial hypertension before the release of closure device.
It also reviews key players involved in the therapeutic development for Pulmonary Arterial Hypertension and special features on late-stage and discontinued projects.
Taking into account the poor prognosis for children with pulmonary arterial hypertension, new medications are needed, said Dr.
PATENT-1 included patients with pulmonary arterial hypertension.
For example, the calculation of relative risk of ischemic stroke in young and elder patients with stenotic lesions of head magisterial arteries and arterial hypertension is presented by Mamatkulov (2008) and illustrated in Table 1.